WORLD Chilean ministers meet with Sinovac executives over potential vaccine production site

WORLD

Chilean ministers meet with Sinovac executives over potential vaccine production site

Xinhua

13:59, July 25, 2021

A worker drives a vehicle to carry containers loaded with vaccines developed by Chinese firm Sinovac Biotech at Santiago international airport in Santiago, Chile, Jan. 28, 2021. (File photo: Xinhua)

SANTIAGO, July 24 (Xinhua) -- Chilean government ministers have met with executives from Chinese company Sinovac in the northern region of Antofagasta over the pharmaceutical firm's plan to create a presence in Chile.

The group visited a plot of land 28 km north of the city of Antofagasta on Friday, which could be the site of a future production plant for COVID-19 vaccines, said the Chilean Ministry of Health.

It is estimated that the construction of the plant would be completed by the end of 2022, allowing the plant to be put into operation in 2023, said the ministry, adding it would require an investment of about 60 million U.S. dollars.

The plant could "produce vaccines not only for Chile, but also for the rest of Latin America," Health Minister Enrique Paris said.

Sinovac Vice President Meng Weining said that the company had "achieved a production of 4 billion doses (of vaccine) per year."

"We have carried out clinical studies in this country, which have reaffirmed the excellence of Chilean medical and scientific teams," Meng added.

Currently, Chile has fully vaccinated 78.59 percent of its target population against COVID-19, equivalent to almost 12 million people.

The country has registered 1,607,749 cases and 34,958 deaths from COVID-19 so far. Enditem

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue